Table 1.
Patient sociodemographic and clinical characteristics
| Age | 56 (51, 63)a |
| Gender | |
| Male | 74 (70.5) |
| Ethnicity | |
| White | 88 (83.8) |
| Education | |
| Less than a bachelor's degree (< 15 years of education) | 78 (74.2) |
| Profession | |
| Employed | 50 (47.6) |
| Sexual preference | |
| Heterosexual | 62 (59) |
| Homosexual | 25 (23.8) |
| Source of HIV transmission | |
| Heterosexual | 45 (42.9) |
| Men who have sex with men | 41 (39) |
| Number of co‐treatments | |
| One | 19 (18) |
| Two | 27 (25) |
| More than two | 59 (56) |
| Therapeutic classes of co‐treatment | |
| Cardiovascular drugs | 79 (75.2) |
| Antidepressants | 44 (42) |
| Anxiolytics | 31 (29.5) |
| Anti‐osteoporosis drugs | 29 (27.6) |
| Oral antidiabetic drugs | 16 (15.2) |
| HIV laboratory and clinical data | |
| Undetectable HIV RNA (< 50 copies/mL) | 102 (97) |
| CD4 count nadir (cells/μL) | 137 (64, 257)a |
| CD4 count (cells/μL) | 707 (502, 918)a |
| Time since HIV diagnosis (years) | 16.51 (11.6, 24.7)a |
| Alcohol consumption | |
| ≤ 1 time monthly | 52 (49.5) |
| 2−4 times monthly | 18 (17.1) |
| 2−3 times weekly | 18 (17.1) |
| Missing data | 17 (16.1) |
| Injecting drug user | 3 (2.8) |
| Adherence (self‐reported) | |
| Adherent to cART | 87 (82.9) |
| Adherent to co‐treatments | 75 (71.4) |
| Self‐reported co‐treatments patients would be most likely to forget or not take (if any)b | |
| Cardiovascular drugs | 14 (13.3) |
| Antidepressants and anxiolytics | 8 (7.6) |
| Anti‐osteoporosis drugs | 4 (3.8) |
| Oral antidiabetic drugs | 1 (0.95) |
| Morning doses of co‐treatments | 12 (11.4) |
| Noon‐time doses of co‐treatments | 5 (4.8) |
| Evening doses of co‐treatments | 17 (16.2) |
| All co‐treatments | 3 (2.9) |
| Total | 105 |
cART, combination antiretroviral therapy.
Values are expressed as n (%) unless otherwise indicated.
a
Expressed as median (Q1, Q3).
b
Patients had the options to select multiple answers and to write the name of the co‐treatment(s).